Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 6

Results: 32

Sustained major molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood stem cell transplantation in a patient with imatinib-resistant myeloblastic-phase chronic myeloid leukaemia.

Published in:

2009

By:

Rea, D.;
Raffoux, E.;
Cayuela, J.-M.;
Maarek, O.;
Dombret, H.

Publication type:

Letter

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.

Published in:

2009

By:

Mraz, M.;
Malinova, K.;
Kotaskova, J.;
Pavlova, S.;
Tichy, B.;
Malcikova, J.;
Kozubik, K. Stano;
Smardova, J.;
Brychtova, Y.;
Doubek, M.;
Trbusek, M.;
Mayer, J.;
Pospisilova, S.;
Stano Kozubik, K

Publication type:

Letter

Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.

Published in:

2009

By:

Boyd, E. M.;
Bench, A. J.;
Vaghela, K. J.;
Campbell, G. N.;
Chowdhury, F. B.;
Gudgin, E. J.;
Scott, M. A.;
Erber, W. N.

Publication type:

Letter

Depletion of L-asparagine supply and apoptosis of leukemia cells induced by human glycosylasparaginase.

Published in:

2009

By:

Kelo, E.;
Noronkoski, T.;
Mononen, I.

Publication type:

Letter

The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1029, doi. 10.1038/leu.2008.395

By:

Gallay, N.;
Dos Santos, C.;
Cuzin, L.;
Bousquet, M.;
Gouy, V. Simmonet;
Chaussade, C.;
Attal, M.;
Payrastre, B.;
Demur, C.;
Récher, C.

Publication type:

Article

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.

Published in:

2009

By:

Flotho, C.;
Claus, R.;
Batz, C.;
Schneider, M.;
Sandrock, I.;
Ihde, S.;
Plass, C.;
Niemeyer, C. M.;
Lübbert, M.;
Lübbert, M

Publication type:

journal article

Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1118, doi. 10.1038/leu.2008.398

By:

Rossi, D.;
Rasi, S.;
Franceschetti, S.;
Capello, D.;
Castelli, A.;
De Paoli, L.;
Ramponi, A.;
Chiappella, A.;
Pogliani, E. M.;
Vitolo, U.;
Kwee, I.;
Bertoni, F.;
Conconi, A.;
Gaidano, G.

Publication type:

Article

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1062, doi. 10.1038/leu.2008.399

By:

Rossi, D.;
Bodoni, C. Lobetti;
Genuardi, E.;
Monitillo, L.;
Drandi, D.;
Cerri, M.;
Deambrogi, C.;
Ricca, I.;
Rocci, A.;
Ferrero, S.;
Bernocco, E.;
Capello, D.;
De Paoli, L.;
Bergui, L.;
Boi, M.;
Omedè, P.;
Massaia, M.;
Tarella, C.;
Passera, R.;
Boccadoro, M.

Publication type:

Article

Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.

Published in:

2009

By:

Sandlund, J. T.;
Pui, C.-H.;
Zhou, Y.;
Behm, F. G.;
Onciu, M.;
Razzouk, B. I.;
Hijiya, N.;
Campana, D.;
Hudson, M. M.;
Ribeiro, R. C.

Publication type:

journal article

Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.

Published in:

2009

By:

Luo, Y.;
Lai, X.-Y.;
Tan, Y.-M.;
Shi, J.-M.;
Zhao, Y.-M.;
Han, X.-Y.;
Zheng, G.-F.;
Zhu, X.-L.;
Sun, J.;
Zheng, Y.-L.;
Wu, G.-Q.;
He, J.-S.;
Chen, S.-Y.;
Jin, A.-Y.;
Xie, W.-Z.;
Ye, X.-J.;
Cai, Z.;
Lin, M.-F.;
Huang, H.

Publication type:

Letter

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1152, doi. 10.1038/leu.2008.402

By:

Kastritis, E.;
Zervas, K.;
Symeonidis, A.;
Terpos, E.;
Delimbassi, S.;
Anagnostopoulos, N.;
Michali, E.;
Zomas, A.;
Katodritou, E.;
Gika, D.;
Pouli, A.;
Christoulas, D.;
Roussou, M.;
Kartasis, Z.;
Economopoulos, T.;
Dimopoulos, M. A.

Publication type:

Article

Vasculogenic mimicry of acute leukemic bone marrow stromal cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1039, doi. 10.1038/leu.2009.10

By:

Mirshahi, P.;
Rafii, A.;
Vincent, L.;
Berthaut, A.;
Varin, R.;
Kalantar, G.;
Marzac, C.;
Calandini, O. A.;
Marie, J.-P.;
Soria, C.;
Soria, J.;
Mirshahi, M.

Publication type:

Article

Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukaemias.

Published in:

2009

By:

Ballabio, E.;
Cantarella, C. D.;
Federico, C.;
Di Mare, P.;
Hall, G.;
Harbott, J.;
Hughes, J.;
Saccone, S.;
Tosi, S.

Publication type:

Letter

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone.

Published in:

2009

By:

Buhl, A. M.;
Novotny, G. W.;
Josefsson, P.;
Nielsen, J. E.;
Pedersen, L. B.;
Geisler, C.;
Rassenti, L. Z.;
Kipps, T. J.;
Jurlander, J.;
Leffers, H.

Publication type:

Letter

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.

Published in:

2009

By:

Van der Velden, V. H. J.;
Corral, L.;
Valsecchi, M. G.;
Jansen, M. W. J. C.;
De Lorenzo, P.;
Cazzaniga, G.;
Panzer-Grümayer, E. R.;
Schrappe, M.;
Schrauder, A.;
Meyer, C.;
Marschalek, R.;
Nigro, L. L.;
Metzler, M.;
Basso, G.;
Mann, G.;
Den Boer, M. L.;
Biondi, A.;
Pieters, R.;
Van Dongen, J. J. M.;
Panzer-Grümayer, E R

Publication type:

journal article

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1131, doi. 10.1038/leu.2009.1

By:

Farina, L.;
Bruno, B.;
Patriarca, F.;
Spina, F.;
Sorasio, R.;
Morelli, M.;
Fanin, R.;
Boccadoro, M.;
Corradini, P.

Publication type:

Article

SOCS3 inhibits TPO-stimulated, but not spontaneous, megakaryocytic growth in primary myelofibrosis.

Published in:

2009

By:

Chaligné, R.;
Tonetti, C.;
Besancenot, R.;
Marty, C.;
Kiladjian, J.-J.;
Socié, G.;
Bordessoule, D.;
Vainchenker, W.;
Giraudier, S.;
Chaligné, R;
Socié, G;
French Intergroup for MPD

Publication type:

Letter

t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals.

Published in:

2009

By:

Lecluse, Y.;
Lebailly, P.;
Roulland, S.;
Gac, A.-C.;
Nadel, B.;
Gauduchon, P.

Publication type:

Letter

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1054, doi. 10.1038/leu.2009.38

By:

Hochhaus, A.;
O'Brien, S. G.;
Guilhot, F.;
Druker, B. J.;
Branford, S.;
Foroni, L.;
Goldman, J. M.;
Müller, M. C.;
Radich, J. P.;
Rudoltz, M.;
Mone, M.;
Gathmann, I.;
Hughes, T. P.;
Larson, R. A.

Publication type:

Article

Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.

Published in:

2009

By:

Iqbal, J.;
Kucuk, C.;
deLeeuw, R. J.;
Srivastava, G.;
Tam, W.;
Geng, H.;
Klinkebiel, D.;
Christman, J. K.;
Patel, K.;
Cao, K.;
Shen, L.;
Dybkaer, K.;
Tsui, I. F. L.;
Ali, H.;
Shimizu, N.;
Au, W. Y.;
Lam, W. L.;
Chan, W. C.

Publication type:

journal article

Characterization of the ubiquitin–proteasome system in bortezomib-adapted cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1098, doi. 10.1038/leu.2009.8

By:

Rückrich, T.;
Kraus, M.;
Gogel, J.;
Beck, A.;
Ovaa, H.;
Verdoes, M.;
Overkleeft, H. S.;
Kalbacher, H.;
Driessen, C.

Publication type:

Article

Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy.

Published in:

2009

By:

Rea, D.;
Etienne, G.;
Corm, S.;
Cony-Makhoul, P.;
Gardembas, M.;
Legros, L.;
Dubruille, V.;
Hayette, S.;
Mahon, F.-X.;
Cayuela, J.-M.;
Nicolini, F. E.

Publication type:

Letter

Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1106, doi. 10.1038/leu.2009.93

By:

Weerkamp, F.;
Dekking, E.;
Ng, Y. Y.;
van der Velden, V. H. J.;
Wai, H.;
Böttcher, S.;
Brüggemann, M.;
van der Sluijs, A. J.;
Koning, A.;
Boeckx, N.;
Van Poecke, N.;
Lucio, P.;
Mendonça, A.;
Sedek, L.;
Szczepański, T.;
Kalina, T.;
Kovac, M.;
Hoogeveen, P. G.;
Flores-Montero, J.;
Orfao, A.

Publication type:

Article

In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node.

Published in:

2009

By:

Cheung, M. C.;
Bailey, D.;
Pennell, N.;
Imrie, K. R.;
Berinstein, N. L.;
Amato, D.;
Ghorab, Z.

Publication type:

Letter

Genes encoding multiple forms of phospholipase A<sub>2</sub> are expressed in immature forms of human leukemic blasts.

Published in:

2009

By:

Fiancette, R.;
Vincent, C.;
Donnard, M.;
Bordessoule, D.;
Turlure, P.;
Trimoreau, F.;
Denizot, Y.

Publication type:

Letter

A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.

Published in:

2009

By:

Drummond, M. W.;
Heaney, N.;
Kaeda, J.;
Nicolini, F. E.;
Clark, R. E.;
Wilson, G.;
Shepherd, P.;
Tighe, J.;
McLintock, L.;
Hughes, T.;
Holyoake, T. L.

Publication type:

Letter

Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia.

Published in:

2009

By:

Put, N.;
Meeus, P.;
Chatelain, B.;
Rack, K.;
Boeckx, N.;
Nollet, F.;
Graux, C.;
Van Den Neste, E.;
Janssens, A.;
Madoe, V.;
Van Hoof, A.;
Bilhou-Nabera, C.;
Wlodarska, I.;
Vandenberghe, P.;
Michaux, L.

Publication type:

Letter

Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL(+) cells.

Published in:

2009

By:

Hiwase, D. K.;
White, D. L.;
Saunders, V. A.;
Kumar, S.;
Melo, J. V.;
Hughes, T. P.

Publication type:

Letter

Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia.

Published in:

2009

By:

Röhrs, S.;
Romani, J.;
Zaborski, M.;
Drexler, H. G.;
Quentmeier, H.

Publication type:

Letter

Antiepileptic drugs reduce efficacy of methotrexate chemotherapy by downregulation of Reduced folate carrier transport activity.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1087, doi. 10.1038/leu.2009.6

By:

Halwachs, S.;
Schäfer, I.;
Seibel, P.;
Honscha, W.

Publication type:

Article

Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.

Published in:

2009

By:

Zebisch, A.;
Haller, M.;
Hiden, K.;
Goebel, T.;
Hoefler, G.;
Troppmair, J.;
Sill, H.

Publication type:

journal article

Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes.

Published in:

Leukemia (08876924), 2009, v. 23, n. 6, p. 1080, doi. 10.1038/leu.2009.7

By:

Kozuma, Y.;
Yuki, S.;
Ninomiya, H.;
Nagasawa, T.;
Kojima, H.

Publication type:

Article